CVS Health (CVS)
(Delayed Data from NYSE)
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
Zacks News
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $67.88, marking a +1.42% move from the previous day.
Pharmacies & Drug Stores Industry Outlook: Prospects Mixed
by Urmimala Biswas
The Retail - Pharmacies and Drug Stores industry is known for heavy consolidations.
CVS Health (CVS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $70.55, marking a -1.77% move from the previous day.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $73.53 in the latest trading session, marking a -0.65% move from the prior day.
Why CVS Health (CVS) Could Beat Earnings Estimates Again
by Zacks Equity Research
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Analyst Blog Highlights: UnitedHealth, CVS Health, Morgan Stanley, Charles Schwab and Uber Technologies
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, CVS Health, Morgan Stanley, Charles Schwab and Uber Technologies
CVS Health's Selling Seasons Strong, Omnicare Arm Upsets
by Zacks Equity Research
CVS Health's (CVS) 2020 PBM selling season remains strong with gross new business and net new business wins.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $72.76, marking a +0.9% move from the previous day.
Top Research Reports for UnitedHealth, CVS & Morgan Stanley
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group (UNH), CVS Health (CVS) and Morgan Stanley (MS).
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $73.86, moving +0.39% from the previous trading session.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $74.29, marking a +0.8% move from the previous day.
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $74.51, marking a +0.17% move from the previous day.
Rite Aid (RAD) Earnings Surpass Estimates in Q3, Stock Up
by Zacks Equity Research
Rite Aid (RAD) posts robust results in third-quarter fiscal 2020. Notably, the bottom line benefits from higher adjusted EBITDA in the quarter.
Walgreens is the Worst Dow Stock Now, Will 2020 Be Different?
by Zacks Equity Research
Despite the dismal performance in recent times, Walgreens (WBA) has chances to bounce back in 2020.
HMO Industry Outlook: Multiple Levers to Drive Growth
by Sapna Bagaria
Aging U.S population, consolidation, use of technology and growing health service businesses provide ample scope for the industry to grow.
CVS Health Rides on Aetna Prospects, Strong Selling Season
by Zacks Equity Research
CVS Health's (CVS) 2020 PBM selling season is approaching closure and the 2021 selling season is ongoing.
The Zacks Analyst Blog Highlights: Toyota, CVS, 3M, Gilead and Goldman
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Toyota, CVS, 3M, Gilead and Goldman
UnitedHealth (UNH) to Buy Diplomat, Expand Pharmacy Services
by Sapna Bagaria
UnitedHealth (UNH) inks an agreement to acquire Diplomat to expand its in-house pharmacy benefit management business.
Top Stock Reports for Toyota, CVS Health & 3M
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Toyota Motor (TM), CVS Health (CVS) and 3M (MMM).
Why Is CVS Health (CVS) Up 3.8% Since Last Earnings Report?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Molina Healthcare Wins Kentucky Medicaid Managed Care Deal
by Zacks Equity Research
Molina Healthcare's (MOH) Kentucky Medicaid Managed Care contract win to aid 2020 premium revenues.
Centene (CNC) Divests IlliniCare as Part of Merger Agreement
by Zacks Equity Research
Centene (CNC) inks a deal to divest IlliniCare to CVS Health to facilitate the pre-announced merger agreement.
CVS Health Set to Acquire Centene's IlliniCare Health Plan
by Zacks Equity Research
CVS Health's (CVS) latest collaboration with Centene is set to expand its Medicaid and Medicare Advantage presence in Illinois.
3 Healthcare Stocks to Counter Tech Encroachment
by Sreyoshi Mukherjee
Traditional U.S. healthcare companies are resorting to vertical integration to counter the tech threat.
The Extreme Risks of Trading Your Own Retirement Assets - November 15, 2019
by Zacks Equity Research
From understanding your risk tolerance to maintaining emotional control, achieving your retirement goals takes a much different investing approach than regular stock trading.